Evidence map›Paper›PMID 33949732›Full record

ArticleHuman brain mapping2021

Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer's disease.

Diana O Svaldi, Joaquín Goñi, Kausar Abbas, Enrico Amico, David G Clark, Charanya Muralidharan, Mario Dzemidzic, John D West, Shannon L Risacher, Andrew J Saykin and 1 more

Abstract read
In one paragraph

Article in Human brain mapping, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A whole-brain functional connectivity model of Alzheimer's disease pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. PRESERVING HUMAN LARGE-SCALE BRAIN CONNECTIVITY FINGERPRINT IDENTIFIABILITY WITH RANDOM PROJECTIONS.Proceedings. IEEE International Symposium on Biomedical Imaging · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Diana O SvaldiIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0001-6265-1931
Joaquín GoñiSchool of Industrial Engineering, Purdue University, West Lafayette, Indiana, USA.
Kausar AbbasSchool of Industrial Engineering, Purdue University, West Lafayette, Indiana, USA.
Enrico AmicoSchool of Industrial Engineering, Purdue University, West Lafayette, Indiana, USA.
David G ClarkIndiana University School of Medicine, Indianapolis, Indiana, USA.
Charanya MuralidharanIndiana University School of Medicine, Indianapolis, Indiana, USA.
Mario DzemidzicIndiana University School of Medicine, Indianapolis, Indiana, USA.
John D WestIndiana University School of Medicine, Indianapolis, Indiana, USA.
Shannon L RisacherIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0002-3304-7943
Andrew J SaykinIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0002-1376-8532
Liana G ApostolovaIndiana University School of Medicine, Indianapolis, Indiana, USA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Early Onset AD Consortium - the LEAD Study (LEADS)U01AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2018 to 2023
$70.3M
Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Early Onset Alzheimer's Disease ConsortiumR56AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2017 to 2017
$7.7M
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's DiseaseR01AG057739 · NIA · TRUSTEES OF INDIANA UNIVERSITY · PI APOSTOLOVA, LIANA G, PERRY, BREA LOUISE · 2018 to 2022
$3.5M
Statistical models for multi-modal brain imaging studies of HIV-associated cognitive declineR01MH108467 · NIMH · INDIANA UNIVERSITY INDIANAPOLIS · PI HAREZLAK, JAROSLAW · 2015 to 2019
$2.0M
Integrative Bioinformatics Approaches to Human Brain Genomics and ConnectomicsR01EB022574 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI SHEN, LI · 2016 to 2019
$1.9M
Social Networks in Alzheimer Disease 2.0.R37AG057739 · NIA · TRUSTEES OF INDIANA UNIVERSITY · PI PERRY, BREA LOUISE · 2024 to 2025
$1.5M
Imaging and genetic biomarkers for Alzheimer's diseaseR01AG040770 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI APOSTOLOVA, LIANA G · 2012 to 2016
$1.4M
Imaging epigenetics of Alzheimer's DiseaseK02AG048240 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI APOSTOLOVA, LIANA G · 2014 to 2016
$434k
Testing the Dysconnection Hypothesis: Novel Connectomics Approaches for Early Detection and Progression of Alzheimer's DiseaseF32AG062157 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI SVALDI, DIANA OTERO · 2018 to 2018
$47k
Alzheimer's AssociationNIAAA NIH HHS P60 AA007611NIA NIH HHS F32 AG062157NIA NIH HHS K02 AG048240NIA NIH HHS NIA F32AG062157NIA NIH HHS NIA K02 AG048240NIA NIH HHS NIA P30 AG010133NIA NIH HHS NIA R01AG040770NIA NIH HHS NIA R01AG057739NIA NIH HHS NIA R56AG057195NIA NIH HHS NIA U01 AG02490NIA NIH HHS NIA U01AG057195NIA NIH HHS P30 AG010133NIA NIH HHS R01 AG040770NIA NIH HHS R37 AG057739NIA NIH HHS R56 AG057195NIA NIH HHS U01 AG024904NIA NIH HHS U01 AG057195NIBIB NIH HHS R01 EB022574NIH HHS NIH P60AA07611NIH HHS NIH R01EB022574NIH HHS NIH R01MH108467NIH HHS NIH U01 AG024904NIMH NIH HHS R01 MH108467
6 · The paper itself

Abstract

Functional connectivity, as estimated using resting state functional MRI, has shown potential in bridging the gap between pathophysiology and cognition. However, clinical use of functional connectivity biomarkers is impeded by unreliable estimates of individual functional connectomes and lack of generalizability of models predicting cognitive outcomes from connectivity. To address these issues, we combine the frameworks of connectome predictive modeling and differential identifiability. Using the combined framework, we show that enhancing the individual fingerprint of resting state functional connectomes leads to robust identification of functional networks associated to cognitive outcomes and also improves prediction of cognitive outcomes from functional connectomes. Using a comprehensive spectrum of cognitive outcomes associated to Alzheimer's disease (AD), we identify and characterize functional networks associated to specific cognitive deficits exhibited in AD. This combined framework is an important step in making individual level predictions of cognition from resting state functional connectomes and in understanding the relationship between cognition and connectivity.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseCognitive DysfunctionConnectomeFemaleHumansMagnetic Resonance ImagingMaleNerve NetADAlzheimer's diseasecognitionfMRIfunctional connectivityfunctional fingerprintingpredictive modelingresting state

Identifiers

PMID33949732
PMCPMC8249900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.